Advertisement

Treatment

  • Mislav Jelaković
  • Silvija Čuković-ČavkaEmail author
Chapter
Part of the Clinical Gastroenterology book series (CG)

Abstract

Treatment of enteropathy in diabetics is demanding, and should focus on both prevention of diabetic gastrointestinal complications and treatment. Up to now, most of the available treatment has been focused on symptom relief, while the preventive strategies are mostly still undergoing research. The most important factor in treatment and prevention of this condition remains a proper level of glycemic control. Several preventive strategies or preventive approaches have been considered and investigated in recent years, such as improvement of nutritional and psychological status, but with no final conclusion. Some new drugs and therapeutic approaches have also emerged recently, with the potential for improving motility or other diabetes-related gastrointestinal symptoms. As celiac disease, like autoimmune enteropathy, occurs in patients with T1D with significantly higher prevalence than in the general population, screening and treatment in diabetics is recommended. The only effective therapy for celiac disease is a life-long gluten-free diet. The combination of gluten-free diet and diabetic diet is sometimes very complicated, and extensive support by a dietitian is mandatory.

Keywords

Diabetes Small intestine Treatment Diabetic enteropathy Preventive strategy Celiac disease Gluten-free diet 

References

  1. 1.
    Faria M, Pavin EJ, Parisi MC, Lorena SL, Brunetto SQ, Ramos CD, et al. Delayed small intestinal transit in patients with long-standing type 1 diabetes mellitus: investigation of the relationships with clinical features, gastric emptying, psychological distress, and nutritional parameters. Diabetes Technol Ther. 2013;15(1):32.CrossRefPubMedGoogle Scholar
  2. 2.
    Sadik R, Abrahamsson H, Stotzer PO. Gender differences in gut transit shown with a newly developed radiological procedure. Scand J Gastroenterol. 2003;38:36–42.CrossRefPubMedGoogle Scholar
  3. 3.
    Sadiya A. Nutritional therapy for the management of diabetic gastroparesis: clinical review. Diabetes Metab Syndr Obes. 2012;5:329–35.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Semenkovich K, Brown ME, Svrakic DM, Lustman PJ. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs. 2015;75(6):577–87.CrossRefPubMedGoogle Scholar
  5. 5.
    Smith KJ, Béland M, Clyde M, Gariépy G, Pagé V, Badawi G, et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013;74(2):89–99.CrossRefPubMedGoogle Scholar
  6. 6.
    Anitha M, Gondha C, Sutliff R, Parsadanian A, Mwangi S, Sitaraman SV, et al. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest. 2006;116(2):344–56.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Shotton HR, Broadbent S, Lincoln J. Prevention and partial reversal of diabetes-induced changes in enteric nerves of the rat ileum by combined treatment with alpha-lipoic acid and evening primrose oil. Auton Neurosci. 2004;111(1):57–65.CrossRefPubMedGoogle Scholar
  8. 8.
    Pereira RV, Tronchini EA, Tashima CM, Alves EP, Lima MM, Zanoni JN. L-glutamine supplementation prevents myenteric neuron loss and has gliatrophic effects in the ileum of diabetic rats. Dig Dis Sci. 2011;56(12):3507–16.CrossRefPubMedGoogle Scholar
  9. 9.
    Zanoni JN, Tronchini EA, Moure SA, Souza ID. Effects of L-glutamine supplementation on the myenteric neurons from the duodenum and cecum of diabetic rats. Arq Gastroenterol. 2011;48(1):66–71.CrossRefPubMedGoogle Scholar
  10. 10.
    De Freitas P, Natali MR, Pereira RV, Miranda Neto MH, Zanoni JN. Myenteric neurons and intestinal mucosa of diabetic rats after ascorbic acid supplementation. World J Gastroenterol. 2008;14(42):6518–24.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Shotton HR, Adams A, Lincoln J. Effect of aminoguanidine treatment on diabetes-induced changes in the myenteric plexus of rat ileum. Auton Neurosci. 2007;132(1–2):16–26.CrossRefPubMedGoogle Scholar
  12. 12.
    da Silva GG, Zanoni JN, Buttow NC. Neuroprotective action of Ginkgo biloba on the enteric nervous system of diabetic rats. World J Gastroenterol. 2011;17(7):898–905.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Zhao M, Liao D, Zhao J. Diabetes-induced mechanophysiological changes in the small intestine and colon. World J Diabetes. 2017;8(6):249–69.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Krishnan B, Babu S, Walker J, Walker AB, Pappachan JM. Gastrointestinal complications of diabetes mellitus. World J Diabetes. 2013;4(3):51–63.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Samsom M, Verhagen MAMT. Intestinal function. In: Horowitz M, Samsom M, editors. Gastrointestinal function in diabetes mellitus. Wiley: Chichester; 2004.Google Scholar
  16. 16.
    Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs. 2009;18:349–58.CrossRefPubMedGoogle Scholar
  17. 17.
    Evers J, Jones JFX, O’Connell PR. Systematic review of animal models used in research of origins and treatments of fecal incontinence. Dis Colon Rectum. 2017;60(6):614–26.CrossRefPubMedGoogle Scholar
  18. 18.
    Collier A, McLaren J, Godwin J, Bal A. Is Clostridium difficile associated with the ‘4C’ antibiotics? A retrospective observational study in diabetic foot ulcer patients. Int J Clin Pract. 2014;68(5):628–32.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Murao S, Hosokawa H. Serotonin 5-HT3 receptor antagonist for treatment of severe diabetic diarrhea. Diabetes Care. 2010;33(3):e38.  https://doi.org/10.2337/dc09-2131.CrossRefPubMedGoogle Scholar
  20. 20.
    Quigley EM. Cisapride: what can we learn from the rise and fall of a prokinetic? J Dig Dis. 2011;12:147–56.CrossRefPubMedGoogle Scholar
  21. 21.
    De La Luz Nieto M, Wu JM, Matthews C, Whitehead WE, Markland AD. Factors associated with fecal incontinence in a nationally representative sample of diabetic women. Int Urogynecol J. 2015;26(10):1483–8.CrossRefGoogle Scholar
  22. 22.
    Stevens JE, Jones KL, Rayner CK, Horowitz M. Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives. Expert Opin Pharmacother. 2013;14(9):1171–86.CrossRefPubMedGoogle Scholar
  23. 23.
    Gatopoulou A, Papanas N, Maltezos E. Diabetic gastrointestinal autonomic neuropathy: current status and new achievements for everyday clinical practice. Eur J Intern Med. 2012;23(6):499–505.CrossRefPubMedGoogle Scholar
  24. 24.
    Song GQ, Sun Y, Foreman RD, Chen JD. Therapeutic potential of spinal cord stimulation for gastrointestinal motility disorders: a preliminary rodent study. Neurogastroenterol Motil. 2014;26(3):377–84.CrossRefPubMedGoogle Scholar
  25. 25.
    Camarca ME, Mozzillo E, Nugnes R, Zito E, Falco M, Fattorusso V, et al. Celiac disease in type 1 diabetes mellitus. Ital J Pediatr. 2012;38:10.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–76. Quiz 677.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Ludvigsson JF, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ, et al. Diagnosis and management of adult celiac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63:1210–28.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Sadiq Butt M, Tahir-Nade em M, Khan MK, et al. Oat: unique among the cereals. Eur J Nutr. 2008;47:68–79.CrossRefPubMedGoogle Scholar
  29. 29.
    Welstead L. The gluten-free diet in the 3rd millennium: rules, risks and opportunities. Diseases. 2015;3:136–49.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Marchese A, Lovati E, Biagi F, Corazza GR. Coeliac disease and type 1 diabetes mellitus: epidemiology, clinical implications and effects of gluten-free diet. Endocrine. 2013;43:1–2.CrossRefPubMedGoogle Scholar
  31. 31.
    Parzanese I, Qehajaj D, Patrinicola F, Aralica M, Chiriva-UInternati M, Stifter S, et al. From pathophysiology to treatment. World J Gastrointest Pathophysiol. 2017;15(8):27–38.CrossRefGoogle Scholar
  32. 32.
    Ozgör B, Selimoglu MA. Coeliac disease and reproductive disorders. Scand J Gastroenterol. 2010;45:395–402.CrossRefPubMedGoogle Scholar
  33. 33.
    Kelly CP, Bai JC, Liu E. Advances in diagnosis and management of celiac disease. Gastroenterology. 2015;148(6):1175–86.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Gastroenterology and HepatologyUniversity Hospital Center ZagrebZagrebCroatia
  2. 2.University of Zagreb School of MedicineZagrebCroatia

Personalised recommendations